OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical and radiological improvement of cavitary Mycobacteroides abscessus disease in cystic fibrosis following initiation of elexacaftor/tezacaftor/ivacaftor
Roderick Gavey, J D Nolan, Vanessa Moore, et al.
Journal of Cystic Fibrosis (2024) Vol. 23, Iss. 5, pp. 1024-1026
Open Access | Times Cited: 5
Roderick Gavey, J D Nolan, Vanessa Moore, et al.
Journal of Cystic Fibrosis (2024) Vol. 23, Iss. 5, pp. 1024-1026
Open Access | Times Cited: 5
Showing 5 citing articles:
The complexities of elexacaftor/tezacaftor/ivacaftor therapeutic drug monitoring in a person with cystic fibrosis and Mycobacterium abscessus pulmonary disease
Claire Y Mou, Daniel Henderson, Angela Matson, et al.
European Clinical Respiratory Journal (2025) Vol. 12, Iss. 1
Open Access
Claire Y Mou, Daniel Henderson, Angela Matson, et al.
European Clinical Respiratory Journal (2025) Vol. 12, Iss. 1
Open Access
Nocardia Isolation in People with Cystic Fibrosis and Non-CF Bronchiectasis: A Multicenter Italian Study
Laura Venditto, Daniela Dolce, Silvia Campana, et al.
Antibiotics (2025) Vol. 14, Iss. 3, pp. 317-317
Open Access
Laura Venditto, Daniela Dolce, Silvia Campana, et al.
Antibiotics (2025) Vol. 14, Iss. 3, pp. 317-317
Open Access
The impact of cystic fibrosis transmembrane conductance regulator (CFTR) modulators on the pulmonary microbiota
Joshua K. Robertson, Joanna B. Goldberg
Microbiology (2025) Vol. 171, Iss. 4
Closed Access
Joshua K. Robertson, Joanna B. Goldberg
Microbiology (2025) Vol. 171, Iss. 4
Closed Access
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division
Giulia Degiacomi, Laurent R. Chiarelli, Olga Riabova, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 4, pp. 107278-107278
Open Access | Times Cited: 3
Giulia Degiacomi, Laurent R. Chiarelli, Olga Riabova, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 4, pp. 107278-107278
Open Access | Times Cited: 3
Modulator-refractory cystic fibrosis: Defining the scope and challenges of an emerging at-risk population
Lindsay Somerville, Borish Larry, Noth Imre, et al.
Therapeutic Advances in Respiratory Disease (2024) Vol. 18
Open Access | Times Cited: 2
Lindsay Somerville, Borish Larry, Noth Imre, et al.
Therapeutic Advances in Respiratory Disease (2024) Vol. 18
Open Access | Times Cited: 2
